CHEK2 and breast carcinoma: In a previous study of our group regarding distant disease-free survival and breast cancer-specific survival of primary BC, no differential effect of adjuvant chemotherapy or endocrine therapy was observed in CHEK2 1100delC compared with non-CHEK2 breast cancer patients (Kriege et al. 2014).